US20180192888A1 - Blood Pressure and Cardiac Monitoring System and Method Thereof - Google Patents

Blood Pressure and Cardiac Monitoring System and Method Thereof Download PDF

Info

Publication number
US20180192888A1
US20180192888A1 US15/564,585 US201715564585A US2018192888A1 US 20180192888 A1 US20180192888 A1 US 20180192888A1 US 201715564585 A US201715564585 A US 201715564585A US 2018192888 A1 US2018192888 A1 US 2018192888A1
Authority
US
United States
Prior art keywords
sensor
target
axis
waveform
blood pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/564,585
Inventor
Seow Yuen Yee
Christian Peters
Thomas Rocznik
Fabian Henrici
Franz Laermer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robert Bosch GmbH
Original Assignee
Robert Bosch GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Bosch GmbH filed Critical Robert Bosch GmbH
Priority to US15/564,585 priority Critical patent/US20180192888A1/en
Publication of US20180192888A1 publication Critical patent/US20180192888A1/en
Assigned to ROBERT BOSCH GMBH reassignment ROBERT BOSCH GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LAERMER, FRANZ, PETERS, CHRISTIAN, HENRICI, FABIAN, YEE, Seow Yuen, Rocznik, Thomas
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006ECG or EEG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022Monitoring a patient using a global network, e.g. telephone networks, internet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02125Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026Measuring blood flow
    • A61B5/0295Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A61B5/1107Measuring contraction of parts of the body, e.g. organ or muscle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/024Measuring pulse rate or heart rate
    • A61B5/02416Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A61B5/1102Ballistocardiography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/04Measuring blood pressure

Definitions

  • This disclosure is related to health monitoring devices, and more particularly, to a blood pressure and cardiac monitoring system and method for monitoring vital signs.
  • the system comprises a sensing assembly and a processor communicatively coupled to the sensing assembly.
  • the sensing assembly comprises a first accelerometer located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second accelerometer located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow.
  • the processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
  • a third sensor located either along the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle is provided.
  • a fourth sensor located along any axis of the target is provided.
  • the fourth sensor is configured to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
  • Embodiments of another disclosure relates to a sensing assembly for monitoring vital signs includes a first sensor located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow.
  • a processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
  • a housing is provided to encapsulate the processor and the sensing assembly.
  • the processor is remotely located outside the sensing assembly and is communicatively coupled to the sensing assembly via a wireless network.
  • FIG. 1 illustrates a block diagram of a blood pressure monitoring system according to an exemplary embodiment of a disclosure
  • FIG. 2 illustrates a target with a blood pressure monitoring system of FIG. 1 placed on a sternum of the target according to a described embodiment of the disclosure
  • FIG. 3 illustrates a sensing assembly for the blood pressure monitoring system of FIG. 1 according to a described embodiment of the disclosure
  • FIG. 4 illustrates a graph of time-dependent waveforms according to an exemplary embodiment of the disclosure.
  • ECG electrocardiography
  • R-peak of the ECG signal can be used in the calculation of time intervals for monitoring blood pressure (e.g. RJ-time interval), R-peak or Q-peak of ECG signal for monitoring cardiac activity (e.g. pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.) or as the trigger to start data measurement/analysis.
  • PEP pre-ejection period
  • SCG sinocardiography
  • BCG ballistocardiography
  • the J-peak of the SCG is labelled as J x -peak for acceleration in the X-axis (also referred as head-to-foot axis), J r -peak in Y-axis (also referred as right-left axis) and J z -peak for acceleration in the Z-axis (also referred as dorso-ventral axis).
  • Accelerometer signal detected on Z-axis also referred as dorso-ventral axis
  • J z -peak can be used with ECG signal (e.g.
  • R-J z or Q-J z time interval to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
  • Accelerometer signal (detected on X-axis (also referred as head-to-foot axis) measures the body recoil movement due to blood flow.
  • J x -peak signifies the time where blood pumps out from the heart and reaches the arches of Aorta blood vessel.
  • R-J x time interval for blood pressure monitoring.
  • R-peak of ECG or J z -peak of accelerometer can be used to trigger the start of measurement.
  • the blood pressure monitoring can also be performed solely using SCG or accelerometers (e.g. J z -J x time interval).
  • J z -peak signifies the time where heart contracts while J x -peak signifies the time where the blood rushes through the arches of the Aorta blood vessel. This time interval is inversely correlated to the blood pressure.
  • J z -peak can also be used as the trigger to start data measurement/analysis.
  • J x -peak can be used in the calculation of time intervals for monitoring blood pressure (e.g. R-J x time interval, J z -J x time interval, or J x with photoplethysmogram (PPG) signal time interval).
  • PPG photoplethysmogram
  • PPG photoplethysmography
  • FIG. 1 illustrates an exemplary embodiment of a blood pressure monitoring system 100 .
  • the system 100 can be either removably worn by a target, i.e. a patient, applied to, or placed at a sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal.
  • the system 100 can be implanted into the target.
  • the system 100 can be integrated into a client device either worn by the target, applied to, or positioned placed at the sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal.
  • the client device may be a patch, a neckless, a chest strap, a pendant, or any suitable device.
  • the system 100 may be a pacemaker, or any suitable implantable device.
  • the system 100 includes a sensing assembly 102 , a processor 104 , a memory 106 , a communication interface 108 , and any suitable computer implemented modules communicatively coupled to each other via a bus.
  • a housing may be provided to encapsulate at least one or more of the sensing assembly 102 , the processor 104 , the memory 106 , and the communication interface 108 .
  • the housing may be formed from a thin film material that allows the target to stretch, bend, twist, squeeze, fold, expand, or combination thereof either worn by the target, applied to, reapplied to, removed from, or positioned placed at the sternum of the target.
  • the memory 106 communicatively coupled to the processor 104 stores computer-readable instructions that, when executed by the processor 104 of the system 100 , causes the system, and more particularly the processor 104 , to perform or monitor vital signs and cardiac activity based on the detected signal transmitted by the sensing assembly 102 .
  • the memory 106 may include any transitory, non-transitory, volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media.
  • the vital signs include body temperature, pulse rate, blood pressure, and respiratory rate.
  • the processor 104 may be of any type, including but not limited to a microprocessor, a microcontroller, a digital signal processor, or any combination thereof.
  • the processor 104 may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers.
  • the processor may be of any type, including but not limited to a microprocessor ( ⁇ P), a microcontroller ( ⁇ C), a digital signal processor (DSP), or any combination thereof.
  • the processor may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers.
  • the sensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram signal (SCG) and ballistocardiogram (BCG) signal.
  • ECG electrocardiogram
  • PPG photoplethysmorgram
  • SCG seismocardiogram
  • BCG ballistocardiogram
  • the sensing assembly 102 is a single-axis sensing assembly.
  • the sensing assembly 102 is a double-axis sensing assembly.
  • the sensing assembly 102 is a multi-axis assembly.
  • the sensing assembly 102 includes at least one sensor device.
  • the sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer.
  • a first sensor device located at a first axis of the target for detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for detecting a second time dependent motion waveform representative of the target's blood flow.
  • Additional sensors provided at a location along any axis of the target to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
  • the system 100 may be a wired computing system or a wireless computing system.
  • the system 100 is a cloud computing device which may be communicated with via the Internet, and which may be co-located or geographically distributed, wherein shared resources, software, and information are provided to computers and other devices on demand for example, as will be appreciated by those skilled in the art.
  • the cloud blood pressure system 100 may be implemented as one or more servers which may be communicated with via the Internet.
  • the system 100 may communicatively couple to a computing device 122 , a server 124 , or a network 126 via one or more links.
  • the link may be wired, wireless, or combination thereof.
  • the wireless communication link may include cellular protocol, data packet protocol, radio frequency protocol, satellite band, infrared channel, or any other protocol able to transmit data among client machines.
  • the wired communication link may include any wired line link.
  • the server 124 may be an application server, a certificate server, a mobile information server, an e-commerce server, a FTP server, a directory server, CMS server, a printer server, a management server, a mail server, a public/private access server, a real-time communication server, a database server, a proxy server, a streaming media server, or the like.
  • the client machine 122 may be a personal computer or desktop computer, a laptop, a cellular or smart phone, a tablet, a personal digital assistant (PDA), a gaming console, an audio device, a video device, an entertainment device such as a television, a vehicle infotainment, a wearable device, a thin client system, a thick client system, or the like.
  • the client machine 122 can in some embodiment be referred to as a single client machine or a single group of client machines, while the server 124 may be referred to as a single server or a single group of servers.
  • a single client machine communicates with more than one server, while in another embodiment a single server communicates with more than one client machine.
  • a single client machine communicates with a single server.
  • the network 126 can comprise one or more sub-networks, and can be installed between any combination of the client machines 122 and the server 124 .
  • the network 126 can be for example a local-area network (LAN), a metropolitan area network (MAN), a wide area network (WAN), a primary network 126 comprised of multiple sub-networks located between the client machines 122 and the server 124 .
  • LAN local-area network
  • MAN metropolitan area network
  • WAN wide area network
  • primary network 126 comprised of multiple sub-networks located between the client machines 122 and the server 124 .
  • Still further embodiments include the network 126 that can be any network types such as a point to point network, a broadcast network, a telecommunication network, a data communication network, a computer network, an ATM (Asynchronous Transfer Mode) network, a SONET (Synchronous Optical Network) network, a SDH (Synchronous Digital Hierarchy) network, a wireless network, a wireline network, and the like.
  • a point to point network a broadcast network
  • a telecommunication network a data communication network
  • a computer network such as a PSTN (Synchronous Optical Network) network, a SDH (Synchronous Digital Hierarchy) network, a wireless network, a wireline network, and the like.
  • ATM Asynchronous Transfer Mode
  • SONET Synchronous Optical Network
  • SDH Synchronous Digital Hierarchy
  • Additional embodiments may include a network of mobile telephone networks that use a protocol to communicate among mobile devices, where the protocol can be for example AMPS, TDMA, CDMA, GSM, GPRS, UMTS, LTE or any other protocol able to transmitdata arnong mobile devices.
  • the protocol can be for example AMPS, TDMA, CDMA, GSM, GPRS, UMTS, LTE or any other protocol able to transmitdata arnong mobile devices.
  • FIG. 2 illustrates a target 202 , such as a user or a patient, with a blood pressure monitoring system 200 according to a described embodiment of the disclosure.
  • the system 200 identical to the system 100 depicted in FIG. 1 is placed on a sternum of the target and configured to continuously, semi-continuously, or synchronously detect or monitor at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, a seismocardiogram (SCG) signal, a ballistocardiogram (BCG) signal or environmental signal.
  • ECG electrocardiogram
  • PPG photoplethysmorgram
  • SCG seismocardiogram
  • BCG ballistocardiogram
  • the system 200 is able to detect the signal that is less affected by motion artifacts.
  • the system 100 may be placed on any location of the body proximal to the sternum of the target.
  • the system 200 is configured to detect the time interval between heart contraction and blood flow. As illustrated, X-axis 204 , Y-axis 206 , and Z-axis 208 are provided.
  • a first sensor device of the system 100 located at a first axis of the target for continuously detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for continuously detecting a second time dependent motion waveform representative of the target's blood flow.
  • the first axis is the dorso-ventral axis and the second axis is the head-to-foot axis.
  • the axis can be interchangeable between x, y, and z depending on position arrangement of the system 200 . If the system 200 is pointing at X-axis 204 , as illustrated in FIG.
  • the first axis is the Z-axis 208 and the second axis is the X-axis 204 .
  • the system 200 is pointing at Y-axis 206 , the first axis is the Z-axis 208 and the second axis is the Y-axis 206 .
  • the sensor devices may be a single-axis sensor device or a double-axis sensor device.
  • the sensor device is a multi-axis sensor device configured to map the resulting vector along the axis of interest, e.g. if the multi-axis sensor device is rotated and not completed aligned with for example the head-to-foot axis.
  • the first and second sensor devices are accelerometers.
  • FIG. 3 illustrates a sensing assembly 102 for the blood pressure monitoring system 100 .
  • the sensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram (SCG) signal and ballistocardiogram (BCG) signal.
  • ECG electrocardiogram
  • PPG photoplethysmorgram
  • SCG seismocardiogram
  • BCG ballistocardiogram
  • the sensing assembly 102 is a single-axis sensing assembly.
  • the sensing assembly 102 is a double-axis sensing assembly.
  • the sensing assembly 102 is a multi-axis assembly.
  • the sensing assembly 102 includes at least one sensor device.
  • the sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer.
  • a first sensor device located at a first axis of the target generates a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target generates a second time dependent motion waveform representative of the target's blood flow.
  • a third sensor device located at either the first or the second axis of the target generates a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle.
  • the first and second sensor devices are accelerometers 102 a , 102 b and the third sensor device 102 c is either an electrode or a ECG sensor.
  • a fourth sensor located along any axis of the target is provided and is configured to either detect attributes from the environment for providing context awareness information or remove motion artifacts (as reference sensor).
  • FIG. 4 illustrates time-dependent waveforms, ECG waveform 300 , a first motion waveform 302 , and a second motion waveform 304 continuously monitored by the blood pressure system to determine the target's vital sign, i.e. blood pressure and cardiac activity (e.g. PEP and its influencing parameters).
  • the ECG waveform 300 generated by the ECG sensor 102 c of the sensing assembly 102 placed on the target represents the electrical excitation of the heart, features a peak 310 .
  • the first motion waveform 302 generated by the first accelerometer 102 a of the sensing assembly 102 represents the chest movement due to the heart contraction or the cardiac activity of the heart.
  • the first motion waveform 302 is a SCG waveform in the Z-axis.
  • the first motion waveform 302 is a BCG waveform in the Z-axis.
  • the second motion waveform 304 generated by the second accelerometer 102 b of the sensing assembly 102 represents the body recoil movement due to the blood flow, features a peak 306 .
  • the second motion waveform 304 is a SCG waveform in the X-axis.
  • the second motion waveform 304 is a BCG waveform in the X-axis.
  • the peak 310 also referred as R-peak of ECG waveform 300 may be used either in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
  • the peak 312 also referred as Q-peak of ECG waveform 300 may also be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Any points along the first motion waveform 302 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
  • the peak 314 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
  • the peak 316 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
  • any points along second motion waveform 304 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity.
  • the peak 306 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity.
  • the time difference between the peaks 306 , 310 is pulse arrival time (PAT).
  • the time difference between any points 312 located along the ECG waveform 300 and the peak 306 of the second motion waveform 304 features the PAT.
  • the point 312 is located at Q.
  • pre-ejection period PEP is defined between two points located along waveforms 300 , 302 .
  • J z1 -peak 314 located along the waveform 302 can be used with point Q 312 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
  • J z2 -peak 316 located along the waveform 302 can be used with point Q 312 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
  • J z1 -peak 314 located along the waveform 302 can be used with peak R 310 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
  • J z2 -peak 316 located along the waveform 302 can be used with peak R 310 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
  • the time difference between J z1 -peak 314 of the waveform 302 and the peak 306 of the waveform 304 features pulse transit time (PTT).
  • the time interval between the J z -peak of the dorso-ventral axis to the J x -peak of the head-to-foot axis signifies the time it takes for the heart to start contracting till the time the blood flow reaches the arches of the aorta.
  • This J z -J x time interval can be used to monitor blood pressure or relative blood pressure.
  • the time interval can also be used to monitor other cardiovascular parameters such as arterial stiffness, as one example.
  • blood pressure can be monitored by measuring the blood flow velocity profile of two PPG signals at two different locations at the time intervals.
  • the blood flow velocity can be measured using a Doppler ultrasonic transducer. This method uses reflection of ultrasonic irradiation of frequency f 0 from the blood in any arteries, e.g. the Aorta, with additional ultrasonic frequencies appearing in the reflected wave spectrum as sidebands at spectral position f 0 +/ ⁇ f, with ⁇ f being a time-dependent function of blood velocity v(t):
  • the peak reading of ⁇ f or its amplitude ⁇ f A corresponds to the peak velocity v A of the blood ejected from the heart into the aorta, and has a correlation to blood pressure.
  • ⁇ f A or v A corresponds to the systolic blood pressure.
  • the measurement of ⁇ f can be done by synchronous demodulation of the reflected ultrasonic signal spectrum with the center frequency f 0 into the base-band, by a combination of mixing stage and low-pass filter, or any suitable FM-demodulation technique.
  • Phase-locked loop demodulators, ratio-detectors, and any suitable active components, depending on the applications, may be used.
  • the sensor device may be any suitable piezoelectric or electrostatic/capacitive bending actuator or bimorph configured to convert an electrical carrier frequency signal at f 0 into an ultrasonic wave, and an incoming ultrasonic wave spectrum is converted back to an electrical signal spectrum for further analysis.
  • at least one accelerometer signal can be used, depending on the application, to trigger the ultrasonic irradiation and evaluation loop, for cross-correlating data, and for providing context-awareness information. More than one accelerometer of the system 200 can also be used to detect if the user is moving or the kind of activity the user is doing, to add additional information to the user. The additional accelerometer can also be utilized to reduce/filter motion artifacts from the J x or J z data.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Hematology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

A blood pressure and cardiac monitoring system includes a sensing assembly, processor, memory, communication interface, and any suitable computer implemented modules communicatively coupled to each other via a bus. The sensing assembly comprises a first, second, and third sensor. The first sensor is located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart, and the second sensor is located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow. The processor is configured to receive the first waveform and the second waveform, and to determine a first time difference between a vital sign present in the first waveform and the second waveform. The third sensor is located either at the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle. At least one of the sensors may be configured to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application No. 62/319,920, filed Apr. 8, 2016, which is incorporated herein by reference.
  • FIELD
  • This disclosure is related to health monitoring devices, and more particularly, to a blood pressure and cardiac monitoring system and method for monitoring vital signs.
  • SUMMARY
  • A summary of certain embodiments disclosed herein is set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of these certain embodiments and that these aspects are not intended to limit the scope of this disclosure. Indeed, this disclosure may encompass a variety of aspects that may not be set forth below.
  • Embodiments of the disclosure related to a blood pressure and cardiac monitoring system are described. For example, the system comprises a sensing assembly and a processor communicatively coupled to the sensing assembly. The sensing assembly comprises a first accelerometer located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second accelerometer located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow. The processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
  • In another embodiment, a third sensor located either along the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle is provided.
  • In yet another embodiment, a fourth sensor located along any axis of the target is provided.
  • In one or more embodiments, the fourth sensor is configured to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
  • Embodiments of another disclosure relates to a sensing assembly for monitoring vital signs includes a first sensor located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow. A processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
  • In one or more embodiments, a housing is provided to encapsulate the processor and the sensing assembly.
  • In one or more embodiments, the processor is remotely located outside the sensing assembly and is communicatively coupled to the sensing assembly via a wireless network.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • These and other features, aspects, and advantages of this disclosure will become better understood when the following detailed description of certain exemplary embodiments is read with reference to the accompanying drawings in which like characters represent like arts throughout the drawings, wherein:
  • FIG. 1 illustrates a block diagram of a blood pressure monitoring system according to an exemplary embodiment of a disclosure;
  • FIG. 2 illustrates a target with a blood pressure monitoring system of FIG. 1 placed on a sternum of the target according to a described embodiment of the disclosure;
  • FIG. 3 illustrates a sensing assembly for the blood pressure monitoring system of FIG. 1 according to a described embodiment of the disclosure; and
  • FIG. 4 illustrates a graph of time-dependent waveforms according to an exemplary embodiment of the disclosure.
  • DETAILED DESCRIPTION
  • One or more specific embodiments will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
  • The following description is presented to enable any person skilled in the art to make and use the described embodiments, and is provided in the context of a particular application and its requirements. Various modifications to the described embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the described embodiments. Thus, the described embodiments are not limited to the embodiments shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein.
  • As used herein, the term “electrocardiography (ECG)” refers to the changes of the electrical potential due to the depolarization of heart muscle. R-peak of the ECG signal can be used in the calculation of time intervals for monitoring blood pressure (e.g. RJ-time interval), R-peak or Q-peak of ECG signal for monitoring cardiac activity (e.g. pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.) or as the trigger to start data measurement/analysis. The term “seismocardiography (SCG)” refers to the acceleration of the sternum caused by the cardiac activity of the heart while the term “ballistocardiography (BCG)” refers to the changes in the center of mass of the body due to blood flow or heart activity. The J-peak of the RJ-time interval comes from the peak obtained from either SCG or BCG. In an example case where a tri-axis accelerometer is used for SCG measurement, the J-peak of the SCG is labelled as Jx-peak for acceleration in the X-axis (also referred as head-to-foot axis), Jr-peak in Y-axis (also referred as right-left axis) and Jz-peak for acceleration in the Z-axis (also referred as dorso-ventral axis). Accelerometer signal detected on Z-axis (also referred as dorso-ventral axis) measures the chest movement due to heart contraction. Jz-peak can be used with ECG signal (e.g. R-Jz or Q-Jz time interval) to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. Accelerometer signal (detected on X-axis (also referred as head-to-foot axis) measures the body recoil movement due to blood flow. Jx-peak signifies the time where blood pumps out from the heart and reaches the arches of Aorta blood vessel. One example will be R-Jx time interval for blood pressure monitoring. In the measurement of the time intervals, R-peak of ECG or Jz-peak of accelerometer can be used to trigger the start of measurement.
  • The blood pressure monitoring can also be performed solely using SCG or accelerometers (e.g. Jz-Jx time interval). Jz-peak signifies the time where heart contracts while Jx-peak signifies the time where the blood rushes through the arches of the Aorta blood vessel. This time interval is inversely correlated to the blood pressure. Jz-peak can also be used as the trigger to start data measurement/analysis. Jx-peak can be used in the calculation of time intervals for monitoring blood pressure (e.g. R-Jx time interval, Jz-Jx time interval, or Jx with photoplethysmogram (PPG) signal time interval). The term “photoplethysmography (PPG)” refers to the changes in light adsorption in blood. Depending on the position where the PPG data is taken, the time interval between R-peak with PPG, Jz-peak (from SCG) with PPG, Jx-peak (from SCG) with PPG, PPG in one location with PPG in another location, can be used to monitor blood pressure or blood flow velocity.
  • FIG. 1 illustrates an exemplary embodiment of a blood pressure monitoring system 100. The system 100 can be either removably worn by a target, i.e. a patient, applied to, or placed at a sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal. In some embodiments, the system 100 can be implanted into the target. In another embodiment, the system 100 can be integrated into a client device either worn by the target, applied to, or positioned placed at the sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal. As some examples, the client device may be a patch, a neckless, a chest strap, a pendant, or any suitable device. If the system 100 is implantable into the target, the system 100 may be a pacemaker, or any suitable implantable device. The system 100 includes a sensing assembly 102, a processor 104, a memory 106, a communication interface 108, and any suitable computer implemented modules communicatively coupled to each other via a bus. A housing may be provided to encapsulate at least one or more of the sensing assembly 102, the processor 104, the memory 106, and the communication interface 108. In one embodiment, the housing may be formed from a thin film material that allows the target to stretch, bend, twist, squeeze, fold, expand, or combination thereof either worn by the target, applied to, reapplied to, removed from, or positioned placed at the sternum of the target. The memory 106 communicatively coupled to the processor 104 stores computer-readable instructions that, when executed by the processor 104 of the system 100, causes the system, and more particularly the processor 104, to perform or monitor vital signs and cardiac activity based on the detected signal transmitted by the sensing assembly 102. The memory 106 may include any transitory, non-transitory, volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media. The vital signs include body temperature, pulse rate, blood pressure, and respiratory rate.
  • The processor 104 may be of any type, including but not limited to a microprocessor, a microcontroller, a digital signal processor, or any combination thereof. The processor 104 may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers. Depending on the desired configuration, the processor may be of any type, including but not limited to a microprocessor (μP), a microcontroller (μC), a digital signal processor (DSP), or any combination thereof. The processor may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers. The example processor cores may (each) include an arithmetic logic unit (ALU), a floating point unit (FPU), a digital signal processing core (DSP Core), or any combination thereof. An example memory controller may also be used with the processor, or in some implementations the memory controller may be an internal part of the processor. The communication interface 108 allows software and data to be transferred between a computer system external to the system 100 and the system in the form of signals which may be, for example, electronic, electromagnetic, optical, or other signals capable of being received by the communication interface. The communication interface may be for example a modem, a network interface, a communication port, a PCM-CIA slot and card, or the like. The sensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram signal (SCG) and ballistocardiogram (BCG) signal. In one embodiment, the sensing assembly 102 is a single-axis sensing assembly. In another embodiment, the sensing assembly 102 is a double-axis sensing assembly. In yet another embodiment, the sensing assembly 102 is a multi-axis assembly. As an example, the sensing assembly 102 includes at least one sensor device. The sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer. As an example, a first sensor device located at a first axis of the target for detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for detecting a second time dependent motion waveform representative of the target's blood flow. Additional sensors provided at a location along any axis of the target to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
  • The system 100 may be a wired computing system or a wireless computing system. In one embodiment, the system 100 is a cloud computing device which may be communicated with via the Internet, and which may be co-located or geographically distributed, wherein shared resources, software, and information are provided to computers and other devices on demand for example, as will be appreciated by those skilled in the art. In another embodiment, the cloud blood pressure system 100 may be implemented as one or more servers which may be communicated with via the Internet. The system 100 may communicatively couple to a computing device 122, a server 124, or a network 126 via one or more links. The link may be wired, wireless, or combination thereof. The wireless communication link may include cellular protocol, data packet protocol, radio frequency protocol, satellite band, infrared channel, or any other protocol able to transmit data among client machines. The wired communication link may include any wired line link.
  • Depending on the application, one or more servers may be communicatively coupled to the computing device 122 to and the system 100. The server 124 may be an application server, a certificate server, a mobile information server, an e-commerce server, a FTP server, a directory server, CMS server, a printer server, a management server, a mail server, a public/private access server, a real-time communication server, a database server, a proxy server, a streaming media server, or the like. The client machine 122 may be a personal computer or desktop computer, a laptop, a cellular or smart phone, a tablet, a personal digital assistant (PDA), a gaming console, an audio device, a video device, an entertainment device such as a television, a vehicle infotainment, a wearable device, a thin client system, a thick client system, or the like. The client machine 122 can in some embodiment be referred to as a single client machine or a single group of client machines, while the server 124 may be referred to as a single server or a single group of servers. In one embodiment a single client machine communicates with more than one server, while in another embodiment a single server communicates with more than one client machine. In yet another embodiment, a single client machine communicates with a single server. The network 126 can comprise one or more sub-networks, and can be installed between any combination of the client machines 122 and the server 124. In some embodiments, the network 126 can be for example a local-area network (LAN), a metropolitan area network (MAN), a wide area network (WAN), a primary network 126 comprised of multiple sub-networks located between the client machines 122 and the server 124. Still further embodiments include the network 126 that can be any network types such as a point to point network, a broadcast network, a telecommunication network, a data communication network, a computer network, an ATM (Asynchronous Transfer Mode) network, a SONET (Synchronous Optical Network) network, a SDH (Synchronous Digital Hierarchy) network, a wireless network, a wireline network, and the like. Depending on the application, other networks may be used so that data exchanged between the client machine and the server can be transmitted over the network. Network topology of the network 124 can differ within different embodiments which may include a. bus network topology, a star network topology, a ring network topology, a repeater-based network topology, or a tiered-star network topology. Additional embodiments may include a network of mobile telephone networks that use a protocol to communicate among mobile devices, where the protocol can be for example AMPS, TDMA, CDMA, GSM, GPRS, UMTS, LTE or any other protocol able to transmitdata arnong mobile devices.
  • FIG. 2 illustrates a target 202, such as a user or a patient, with a blood pressure monitoring system 200 according to a described embodiment of the disclosure. The system 200 identical to the system 100 depicted in FIG. 1 is placed on a sternum of the target and configured to continuously, semi-continuously, or synchronously detect or monitor at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, a seismocardiogram (SCG) signal, a ballistocardiogram (BCG) signal or environmental signal. In some embodiments, the system 200 is placed on the sternum of the target for sensing movement of the chest wall. Since bones can transfer the body movement due to cardiac activities with less damping effects than muscles, the system 200 is able to detect the signal that is less affected by motion artifacts. In another embodiment, the system 100 may be placed on any location of the body proximal to the sternum of the target. In yet another embodiment, the system 200 is configured to detect the time interval between heart contraction and blood flow. As illustrated, X-axis 204, Y-axis 206, and Z-axis 208 are provided. A first sensor device of the system 100 located at a first axis of the target for continuously detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for continuously detecting a second time dependent motion waveform representative of the target's blood flow. The first axis is the dorso-ventral axis and the second axis is the head-to-foot axis. The axis can be interchangeable between x, y, and z depending on position arrangement of the system 200. If the system 200 is pointing at X-axis 204, as illustrated in FIG. 2 the first axis is the Z-axis 208 and the second axis is the X-axis 204. In another embodiment, the system 200 is pointing at Y-axis 206, the first axis is the Z-axis 208 and the second axis is the Y-axis 206. The sensor devices may be a single-axis sensor device or a double-axis sensor device. In another embodiment, the sensor device is a multi-axis sensor device configured to map the resulting vector along the axis of interest, e.g. if the multi-axis sensor device is rotated and not completed aligned with for example the head-to-foot axis. As illustrated, the first and second sensor devices are accelerometers.
  • FIG. 3 illustrates a sensing assembly 102 for the blood pressure monitoring system 100. The sensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram (SCG) signal and ballistocardiogram (BCG) signal. In one embodiment, the sensing assembly 102 is a single-axis sensing assembly. In another embodiment, the sensing assembly 102 is a double-axis sensing assembly. In yet another embodiment, the sensing assembly 102 is a multi-axis assembly. As an example, the sensing assembly 102 includes at least one sensor device. The sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer. As an example, a first sensor device located at a first axis of the target generates a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target generates a second time dependent motion waveform representative of the target's blood flow. As another example, a third sensor device located at either the first or the second axis of the target generates a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle. In one embodiment, the first and second sensor devices are accelerometers 102 a, 102 b and the third sensor device 102 c is either an electrode or a ECG sensor. In another embodiment, a fourth sensor located along any axis of the target is provided and is configured to either detect attributes from the environment for providing context awareness information or remove motion artifacts (as reference sensor).
  • FIG. 4 illustrates time-dependent waveforms, ECG waveform 300, a first motion waveform 302, and a second motion waveform 304 continuously monitored by the blood pressure system to determine the target's vital sign, i.e. blood pressure and cardiac activity (e.g. PEP and its influencing parameters). The ECG waveform 300, generated by the ECG sensor 102 c of the sensing assembly 102 placed on the target represents the electrical excitation of the heart, features a peak 310. The first motion waveform 302 generated by the first accelerometer 102 a of the sensing assembly 102 represents the chest movement due to the heart contraction or the cardiac activity of the heart. In one embodiment, the first motion waveform 302 is a SCG waveform in the Z-axis. In another embodiment, the first motion waveform 302 is a BCG waveform in the Z-axis. The second motion waveform 304, generated by the second accelerometer 102 b of the sensing assembly 102 represents the body recoil movement due to the blood flow, features a peak 306. In one embodiment, the second motion waveform 304 is a SCG waveform in the X-axis. In another embodiment, the second motion waveform 304 is a BCG waveform in the X-axis. The peak 310 also referred as R-peak of ECG waveform 300 may be used either in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. The peak 312 also referred as Q-peak of ECG waveform 300 may also be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Any points along the first motion waveform 302 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. As an example, the peak 314 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. As another example, the peak 316 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Any points along second motion waveform 304 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity. As one example, the peak 306 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity. In one embodiment, the time difference between the peaks 306, 310 is pulse arrival time (PAT). In another embodiment, the time difference between any points 312 located along the ECG waveform 300 and the peak 306 of the second motion waveform 304 features the PAT. As an example, the point 312 is located at Q. As described previously, pre-ejection period (PEP) is defined between two points located along waveforms 300, 302. In one embodiment, Jz1-peak 314 located along the waveform 302 can be used with point Q 312 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. In yet another embodiment, Jz2-peak 316 located along the waveform 302 can be used with point Q 312 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. In yet another embodiment, Jz1-peak 314 located along the waveform 302 can be used with peak R 310 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. In further yet another embodiment, Jz2-peak 316 located along the waveform 302 can be used with peak R 310 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. As one embodiment, the time difference between Jz1-peak 314 of the waveform 302 and the peak 306 of the waveform 304 features pulse transit time (PTT).
  • The time interval between the Jz-peak of the dorso-ventral axis to the Jx-peak of the head-to-foot axis signifies the time it takes for the heart to start contracting till the time the blood flow reaches the arches of the aorta. This Jz-Jx time interval can be used to monitor blood pressure or relative blood pressure. The time interval can also be used to monitor other cardiovascular parameters such as arterial stiffness, as one example.
  • As described above, blood pressure can be monitored by measuring the blood flow velocity profile of two PPG signals at two different locations at the time intervals. Alternatively, the blood flow velocity can be measured using a Doppler ultrasonic transducer. This method uses reflection of ultrasonic irradiation of frequency f0 from the blood in any arteries, e.g. the Aorta, with additional ultrasonic frequencies appearing in the reflected wave spectrum as sidebands at spectral position f0+/−Δf, with Δf being a time-dependent function of blood velocity v(t):

  • Δf(t)=Δf(v)=Δf(v(t))
  • The peak reading of Δf or its amplitude ΔfA corresponds to the peak velocity vA of the blood ejected from the heart into the aorta, and has a correlation to blood pressure. ΔfA or vA corresponds to the systolic blood pressure.
  • The minimum reading of Δf in between 2 maxima ΔfA, namely Δfmin has a correlation to the minimum blood velocity vmin and to blood pressure as well. Δfmin or vmin corresponds to the diastolic blood pressure.
  • The measurement of Δf can be done by synchronous demodulation of the reflected ultrasonic signal spectrum with the center frequency f0 into the base-band, by a combination of mixing stage and low-pass filter, or any suitable FM-demodulation technique. Phase-locked loop demodulators, ratio-detectors, and any suitable active components, depending on the applications, may be used.
  • In yet another embodiment, the sensor device may be any suitable piezoelectric or electrostatic/capacitive bending actuator or bimorph configured to convert an electrical carrier frequency signal at f0 into an ultrasonic wave, and an incoming ultrasonic wave spectrum is converted back to an electrical signal spectrum for further analysis. In addition, at least one accelerometer signal can be used, depending on the application, to trigger the ultrasonic irradiation and evaluation loop, for cross-correlating data, and for providing context-awareness information. More than one accelerometer of the system 200 can also be used to detect if the user is moving or the kind of activity the user is doing, to add additional information to the user. The additional accelerometer can also be utilized to reduce/filter motion artifacts from the Jx or Jz data.
  • The embodiments described above have been shown by way of example, and it should be understood that these embodiments may be susceptible to various modifications and alternative forms. It should be further understood that the claims are not intended to be limited to the particular forms disclosed, but rather to cover all modifications, equivalents, and alternatives falling with the sprit and scope of this disclosure.
  • While the patent has been described with reference to various embodiments, it will be understood that these embodiments are illustrative and that the scope of the disclosure is not limited to them. Many variations, modifications, additions, and improvements are possible. More generally, embodiments in accordance with the patent have been described in the context or particular embodiments. Functionality may be separated or combined in blocks differently in various embodiments of the disclosure or described with different terminology. These and other variations, modifications, additions, and improvements may fall within the scope of the disclosure as defined in the claims that follow.

Claims (14)

What is claimed is:
1. A blood pressure and cardiac monitoring system comprising:
a sensing assembly comprising:
a first accelerometer located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart; and
a second accelerometer located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow; and
a processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine:
a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
2. The blood pressure and cardiac monitoring system of claim 1 further comprising at least one of a memory and a communication interface.
3. The blood pressure and cardiac monitoring system of claim 1 further comprising a third sensor located either at the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle.
4. The blood pressure and cardiac monitoring system of claim 1 wherein the system is integrated into a client device and the processor is disposed in the client device.
5. The blood pressure and cardiac monitoring system of claim 1 wherein the system is integrated into a client device and the processor is disposed in the system.
6. The blood pressure and cardiac monitoring system of claim 1 wherein the system is a cloud computing device.
7. The blood pressure and cardiac monitoring system of claim 1 wherein the system is communicatively coupled to at least one of a client device, a server, and a network.
8. The blood pressure and cardiac monitoring system of claim 3 wherein the third sensor is selected from a group consisting of an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a sonar sensor, a thermal sensor, an environmental sensor, and a target orientation sensor.
9. A sensing assembly for monitoring vital signs comprising:
a first sensor located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart; and
a second sensor located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow; and
a processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine:
a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
10. The sensing assembly of claim 9 further comprising a third sensor located either at the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle.
11. The sensing assembly of claim 9 wherein the assembly is integrated into a client device and the processor is disposed in the client device.
12. The sensing assembly of claim 9 wherein the assembly is a cloud computing device.
13. The sensing assembly of claim 9 wherein the assembly is communicatively coupled to at least one of a client device, a server, and a network.
14. The sensing assembly of claim 10 wherein the sensor is selected from a group consisting of an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a sonar sensor, a thermal sensor, an environmental sensor, and a target orientation sensor.
US15/564,585 2016-04-08 2017-04-10 Blood Pressure and Cardiac Monitoring System and Method Thereof Abandoned US20180192888A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/564,585 US20180192888A1 (en) 2016-04-08 2017-04-10 Blood Pressure and Cardiac Monitoring System and Method Thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662319920P 2016-04-08 2016-04-08
PCT/EP2017/058487 WO2017174814A1 (en) 2016-04-08 2017-04-10 Blood pressure and cardiac monitoring system and method thereof
US15/564,585 US20180192888A1 (en) 2016-04-08 2017-04-10 Blood Pressure and Cardiac Monitoring System and Method Thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/058487 A-371-Of-International WO2017174814A1 (en) 2016-04-08 2017-04-10 Blood pressure and cardiac monitoring system and method thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/834,686 Continuation-In-Part US11051705B2 (en) 2016-04-08 2017-12-07 Blood pressure and cardiac monitoring system and method thereof

Publications (1)

Publication Number Publication Date
US20180192888A1 true US20180192888A1 (en) 2018-07-12

Family

ID=58536977

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/564,585 Abandoned US20180192888A1 (en) 2016-04-08 2017-04-10 Blood Pressure and Cardiac Monitoring System and Method Thereof
US15/834,686 Active 2039-04-23 US11051705B2 (en) 2016-04-08 2017-12-07 Blood pressure and cardiac monitoring system and method thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/834,686 Active 2039-04-23 US11051705B2 (en) 2016-04-08 2017-12-07 Blood pressure and cardiac monitoring system and method thereof

Country Status (3)

Country Link
US (2) US20180192888A1 (en)
EP (1) EP3463066B1 (en)
WO (1) WO2017174814A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200100705A1 (en) * 2017-06-23 2020-04-02 Koninklijke Philips N.V. Device, system and method for detection of pulse and/or pulse-related information of a patient
WO2020205987A1 (en) * 2019-04-01 2020-10-08 VivaLnk, Inc. Systems, devices, and methods for non-invasive cardiac monitoring
US11504047B2 (en) 2017-12-28 2022-11-22 Heart Force Medical Inc. Sensor apparatuses, methods of operating same, and systems including same, and methods and systems for sensing and analyzing electromechanical characteristics of a heart
WO2023158985A1 (en) * 2022-02-15 2023-08-24 Cardiosounds Llc Vibro-acoustic modeling of cardiac activity

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10849508B2 (en) * 2016-06-03 2020-12-01 Fourth Frontier Technologies Pvt. Ltd. System and method for continuous monitoring of blood pressure
US11660052B2 (en) 2017-11-09 2023-05-30 Robert Bosch Gmbh Vital signs monitoring system and method
WO2019162490A1 (en) * 2018-02-26 2019-08-29 Robert Bosch Gmbh Wearable health device system with normalized seismocardiography signals
CN108852322A (en) * 2018-02-26 2018-11-23 南京邮电大学 It is a kind of based on PWV without constraint blood pressure measuring system
CN108324260A (en) * 2018-02-28 2018-07-27 湖南可孚医疗科技发展有限公司 A kind of blood pressure monitoring system based on big data
US11185237B2 (en) * 2018-03-06 2021-11-30 Robert Bosch Gmbh Calibration methods for blood pressure devices
FI20186044A1 (en) * 2018-12-04 2020-06-05 Myllylae Teemu Biosignal measurement apparatus and method
US12023165B2 (en) 2020-10-23 2024-07-02 Northwestern University Screening cardiac conditions using cardiac vibrational energy spectral heat maps

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8475370B2 (en) * 2009-05-20 2013-07-02 Sotera Wireless, Inc. Method for measuring patient motion, activity level, and posture along with PTT-based blood pressure
US20110066041A1 (en) * 2009-09-15 2011-03-17 Texas Instruments Incorporated Motion/activity, heart-rate and respiration from a single chest-worn sensor, circuits, devices, processes and systems
WO2014036436A1 (en) * 2012-08-30 2014-03-06 Alivecor, Inc. Cardiac performance monitoring system for use with mobile communications devices
US10856742B2 (en) * 2014-02-06 2020-12-08 Sotera Wireless, Inc. Body-worn system for continuous, noninvasive measurement of vital signs
US20160081563A1 (en) * 2014-09-23 2016-03-24 PhysioWave, Inc. Systems and methods to estimate or measure hemodynamic output and/or related cardiac output

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200100705A1 (en) * 2017-06-23 2020-04-02 Koninklijke Philips N.V. Device, system and method for detection of pulse and/or pulse-related information of a patient
US11957454B2 (en) * 2017-06-23 2024-04-16 Koninklijke Philips N.V. Device, system and method for detection of pulse and/or pulse-related information of a patient
US11504047B2 (en) 2017-12-28 2022-11-22 Heart Force Medical Inc. Sensor apparatuses, methods of operating same, and systems including same, and methods and systems for sensing and analyzing electromechanical characteristics of a heart
WO2020205987A1 (en) * 2019-04-01 2020-10-08 VivaLnk, Inc. Systems, devices, and methods for non-invasive cardiac monitoring
WO2023158985A1 (en) * 2022-02-15 2023-08-24 Cardiosounds Llc Vibro-acoustic modeling of cardiac activity

Also Published As

Publication number Publication date
EP3463066B1 (en) 2023-08-16
EP3463066A1 (en) 2019-04-10
WO2017174814A1 (en) 2017-10-12
US11051705B2 (en) 2021-07-06
US20180092533A1 (en) 2018-04-05

Similar Documents

Publication Publication Date Title
US11051705B2 (en) Blood pressure and cardiac monitoring system and method thereof
US11660052B2 (en) Vital signs monitoring system and method
US11691001B2 (en) Methods for transcutaneous facial nerve stimulation and applications thereof
US11826119B2 (en) Internet-linked ultrasonic network for medical devices
Chandrasekaran et al. Cuffless differential blood pressure estimation using smart phones
US9566033B2 (en) Garment system with electronic components and associated methods
JP6150952B2 (en) Method and apparatus for determining the direction of an accelerometer
US20160206277A1 (en) Systems and methods for monitoring heart rate using acoustic sensing
JP7116810B2 (en) Wearable Computers with Connectivity to Health Devices for Improved Behavioral Monitoring Using Calorie Expenditure Models
WO2014078210A3 (en) Piezoelectric heart rate sensing for wearable devices or mobile devices
KR102534876B1 (en) Method and apparatus for determining the breathing status of a person using a depth camera
Horng et al. The smart fall detection mechanism for healthcare under free-living conditions
Erfianto et al. IMU‐Based respiratory signal processing using cascade complementary filter method
JP2017059089A (en) Step counting device, step counting method, and program
JP6642055B2 (en) Sensor information processing device, sensor unit, and sensor information processing program
CN114947771A (en) Human body characteristic data acquisition method and device
Wu et al. Accurate stride length estimation via fused radio and inertial sensing
CN117043634A (en) Angular and linear movement detection and compensation for user equipment
CN207574548U (en) A kind of personal jacket and Wearable
Baiamonte et al. Synchronized Vibration Data Acquisition for Seismocardiography
He et al. TreMo: Continuous Vital Sign Monitoring Based on Subtle Intrinsic Tremors with COTS Mobile Devices
Majumder Wearable Systems For Health Monitoring Towards Active Aging
CN118436324A (en) Pulse arrival time difference acquisition method, central blood pressure acquisition method and device
CN116720096A (en) Movement assessment methods, electronic devices and systems
KR20160011958A (en) A wearable sensing device for detecting biological signal and information on exercise

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: ROBERT BOSCH GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YEE, SEOW YUEN;PETERS, CHRISTIAN;ROCZNIK, THOMAS;AND OTHERS;SIGNING DATES FROM 20180328 TO 20180504;REEL/FRAME:046856/0510

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION